Dr. Garry Duffy presented DRIVE at the 3U Partnership Diabetes Research Conference

 

Islet transplantation, a treatment not currently available for people with type 1 diabetes in Ireland, was a major focus of the Fourth Annual 3U Partnership International Diabetes Conference entitled ‘Current Challenges in Diabetes Research’ which took place at RCSI (Royal College of Surgeons in Ireland) in Dublin on Friday 16th January 2016. DRIVE researchers from Irish partners Dublin City University (DCU), Boston Scientific, University College Dublin (UCD) and RCSI were among the attendees.

Among the speakers was DRIVE Coordinator Dr Garry Duffy (RCSI) who introduced the DRIVE Consortium’s smart biomaterial technologies, which have the potential to improve this therapy and broaden its applicability to more type 1 diabetes patients by enhancing the survival of transplanted islets and abolishing the need for systemic immunosuppressive drugs, which have significant negative side effects. 

Read the full article

     This project has received funding from the EU Horizon 2020 research and innovation programme. Grant agreement No 645991